"S2-4 STRATEGIC PROPOSALS FOR AVOIDING TOXIC INTERACTIONS WITH DRUGS FOR CLINICAL USE DURING DEVELOPMENT AND AFTER MARKETING OF A NEW DRUG : PHARMACOKINETIC CONSIDERATION (<SYMPOSIUM 2>Strategy how we can learn drug-drug interaction during the development of a new drug)

Yuichi SUGIYAMA; Takafumi IWATSUBO; Kaoru UEDA; Kiyomi ITO

doi:10.2131/jts.21.5_309

The Journal of Toxicological Sciences

Online ISSN : 1880-3989
Print ISSN : 0388-1350
ISSN-L : 0388-1350

"S2-4 STRATEGIC PROPOSALS FOR AVOIDING TOXIC INTERACTIONS WITH DRUGS FOR CLINICAL USE DURING DEVELOPMENT AND AFTER MARKETING OF A NEW DRUG : PHARMACOKINETIC CONSIDERATION (<SYMPOSIUM 2>Strategy how we can learn drug-drug interaction during the development of a new drug)